Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$16.95 - $27.04 $1.03 Million - $1.65 Million
60,900 Added 14.34%
485,500 $13.1 Million
Q1 2024

May 13, 2024

BUY
$11.38 - $19.03 $2.94 Million - $4.92 Million
258,300 Added 155.32%
424,600 $7.78 Million
Q4 2023

Feb 13, 2024

SELL
$6.29 - $15.72 $259,777 - $649,236
-41,300 Reduced 19.89%
166,300 $2.04 Million
Q3 2023

Nov 14, 2023

SELL
$14.99 - $32.65 $1.97 Million - $4.3 Million
-131,600 Reduced 38.8%
207,600 $3.11 Million
Q2 2023

Aug 11, 2023

SELL
$29.76 - $46.14 $4.59 Million - $7.12 Million
-154,400 Reduced 31.28%
339,200 $11 Million
Q1 2023

May 12, 2023

BUY
$38.09 - $57.79 $12.8 Million - $19.4 Million
336,200 Added 213.6%
493,600 $19.3 Million
Q4 2022

Feb 13, 2023

BUY
$40.54 - $56.2 $6.38 Million - $8.85 Million
157,400 New
157,400 $8.32 Million
Q4 2021

Feb 11, 2022

SELL
$39.32 - $61.61 $1.99 Million - $3.11 Million
-50,492 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$44.0 - $65.8 $576,048 - $861,453
13,092 Added 35.01%
50,492 $2.78 Million
Q2 2021

Aug 13, 2021

SELL
$44.66 - $63.06 $660,968 - $933,288
-14,800 Reduced 28.35%
37,400 $1.79 Million
Q1 2021

May 13, 2021

BUY
$46.31 - $62.7 $1.1 Million - $1.49 Million
23,700 Added 83.16%
52,200 $2.64 Million
Q4 2020

Feb 10, 2021

SELL
$55.51 - $69.94 $2.8 Million - $3.52 Million
-50,400 Reduced 63.88%
28,500 $1.8 Million
Q3 2020

Nov 13, 2020

SELL
$42.19 - $69.61 $1.24 Million - $2.05 Million
-29,400 Reduced 27.15%
78,900 $5.3 Million
Q2 2020

Aug 13, 2020

BUY
$27.55 - $43.28 $2.49 Million - $3.9 Million
90,200 Added 498.34%
108,300 $4.54 Million
Q1 2020

May 14, 2020

BUY
$23.16 - $47.8 $419,196 - $865,180
18,100 New
18,100 $570,000

Others Institutions Holding SILK

About Silk Road Medical Inc


  • Ticker SILK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,565,600
  • Market Cap $1.03B
  • Description
  • Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate te...
More about SILK
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.